Hypera S.A. (OTCMKTS:HYPMY - Get Free Report)'s stock price crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $3.96 and traded as high as $4.91. Hypera shares last traded at $4.91, with a volume of 706 shares trading hands.
Hypera Stock Performance
The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.41 and a current ratio of 1.81. The firm has a fifty day moving average of $4.01 and a 200 day moving average of $3.49. The firm has a market capitalization of $3.11 billion, a PE ratio of 20.46 and a beta of 0.79.
Hypera (OTCMKTS:HYPMY - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported ($0.04) EPS for the quarter. The firm had revenue of $184.34 million for the quarter. Hypera had a return on equity of 13.18% and a net margin of 20.04%.
About Hypera
(
Get Free Report)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Recommended Stories
Before you consider Hypera, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypera wasn't on the list.
While Hypera currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
